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Background: The influenza A (H7N9) virus emerged in the spring of 2013 in China. It contained six internal genes
from Y280-like H9N2 viruses, which have co-circulated with G1-like lineage viruses throughout poultry in China.
Accompanied with continuous reassortment among H7N9 and H9N2 viruses in poultry, it is possible for H7N9
viruses to acquire internal genes of G1-lineage viruses. Thus, it is important to evaluate potential impact of
G1-like viruses on the H7N9 viruses.
Findings: We used in vitro assays of polymerase activities and growth kinetics to evaluate the potential contribution of
G1-like virus genes to the replication abilities of H7N9 viruses. Two mutations in the NP protein (41V and/or 210D) could
enhance H7N9 RNP activities, especially at low temperature (33°C, which is similar to the temperature of human upper
respiratory tract). Meanwhile, G1 viruses with V41I or D210E substitutions exhibited poor growth ability in the early
infection stage at low temperature. The D210E substitution also reduced the replication ability of G1 virus at 12 and
24 hour post infection at 37°C. In both tested temperatures, V41I could compensate for the defective virus replication
induced by the D210E mutation.
Conclusions: Mutations 41V and/or 210D in the NP protein conferred improved RNP activity in H7N9 viruses and
promoted the replication ability of H9N2 viruses, particularly at lower temperature. Substitutions at these two positions
may promote the replication ability of H7N9 viruses in low temperature and thus might contribute to viral
transmissibility. While these two residues have not yet been observed in H7N9 viruses, attention should be
devoted to these two residues.
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The zoonotic transmission of a novel influenza A
(H7N9) virus into humans in February 2013 in Eastern
China has become a global concern [1]. This H7N9 virus
was a reassortant between H7 and N9 viruses, with six
internal genes from Y280-lineage H9N2 avian influenza
viruses. Although studies in avian and mammalian
models such as chickens, pigs, ferrets, and non-human
primates have shown that this virus is of low or mild* Correspondence: yshu@cnic.org.cn
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unless otherwise stated.pathogenicity [2-5], H7N9 infection in humans has often
led to severe outcomes [1,6,7]. Glutamic acid (E)-to-
lysine (K) substitution at position 627 in PB2, one of the
important molecular markers of mammalian-adapted
avian influenza viruses, was reported to be associated
with enhanced virulence of the highly pathogenic H5N1
and H7N7 avian influenza viruses in mice [8,9], and
responsible for viral replication at lower temperatures
(33°C), allowing enhanced growth in the upper respira-
tory tract of mammals and efficient transmission of the
viruses [10-13]. Although there has been limited human-
to-human transmission [14], no highly transmissible
cases have been reported for the novel H7N9 virus. Thisis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lower respiratory tract than the upper respiratory tract
[15], which merits studying the role of viral factors
in transmissibility, especially viral replication at low
temperature (33°C).
Multiple genotypes of H7N9 viruses have been re-
ported via continuous reassortant of their internal genes
with H9N2 viruses in poultry [16]. Additionally, two
different H9N2 lineages, Y280-like and G1-like, co-
circulate in poultry in mainland China [17-19], raising
the possibility for H7N9 viruses to reassort with G1-like
virus. To test whether four RNP complex genes (PB2,
PB1, PA, and NP) of G1-like H9N2 viruses confer any
advantages to those of H7N9 viruses, we first tested all
recombinant RNP activities between A/Quail/Hong
Kong/G1/1997 (H9N2, G1) and A/Anhui/1/2013 (H7N9,
AH1) at 33°C and 37°C. Temperatures of 33°C and 37°C
were used to approximate the conditions of human upper
and lower respiratory tracts, respectively. Reporter plasmid
polI-Gluc [20] was co-transfected with expression plasmids
encoding PB2, PB1, PA, and the NP of G1 or AH1 into
293T cells using the PolyFect (Qiagen, Valencia, CA, USA)
reagent, according to the manufacturer’s instructions. Gluc
activity in supernatants was analyzed in 24 hours post
transfection using a Gluc assay kit (New England Biolabs,A
C
Figure 1 Normalized polymerase activities of recombinant polymerase comp
(H7N9) (A & B), or different NPs in the backbone of A/Anhui/1/2013 (H
in triplicate based on a Gluc reporter system and normalized to AH1 R
G, A/Quail/Hongkong/G1/1997; A, A/Anhui/1/2013; Abbreviations in C &
1997 (H9N2, G1); QH, A/bar-headed goose/Qinghai/1/2005 (H5N1); GZ, A/G
(2009pdmH1N1); and PR8, A/Puerto Rico/8/1934 (H1N1). Results are represeBeverly, MA, USA) and normalized to AH1 RNP activity.
G1 exhibited about 2.5-fold higher RNP activity than AH1
at 37°C (Figure 1B), while at 33°C the RNP of G1 showed
much less activity than AH1 (Figure 1A). PB2-E627K could
have contributed to the better RNP function of AH1
at 33°C, because the G1 virus contained the 627E
residue at PB2 protein. In addition, the AH1-NP led
to decreased RNP activity of G1 at 37°C, while the G1-NP
enhanced the RNP activity of AH1 at both temperatures
(Figure 1A, B).
For a more detailed investigation of the role of different
NPs in viral replication and transcription, we constructed
four NP plasmids from different subtype viruses: A/
bar-headed goose/Qinghai/1/2005 (H5N1, QH1), A/
Guangzhou/333/1999 (H9N2, GZ), A/California/04/2009
(2009pdmH1N1, CA04), and A/Puerto Rico/8/1934
(H1N1, PR8). We co-transfected polI-Gluc with plas-
mids expressing the RdRp subunits of AH1 plus different
NPs into 293T cells, and RNP activities were tested. G1-NP
was the only plasmid that significantly enhanced RNP ac-
tivity of AH1 at 33°C (Figure 1C), and also increased RNP
activity at 37°C about 1.25 fold (Figure 1D).
We then compared the sequences of the six tested
NPs: AH1, G1, QH1, GZ, CA04, and PR8. G1-NP pos-
sessed two specific residues, 41V and 210D, while theB
D
lexes between A/Quail/Hongkong/G1/1997 (H9N2) and A/Anhui/1/2013
7N9) PB2/PB1/PA plasmids (C & D). RNP activities were measured
NP activity at 33°C (A, C) and 37°C (B, D). Abbreviations in A & B:
D: AH, A/Anhui/1/2013 (H7N9, AH1); G1, A/Quail/Hongkong/G1/
uangzhou/333/1999 (H9N2); CA04, A/California/04/2009
ntative of three independent experiments.
A B
Figure 2 Viral RNA polymerase activities of NP-41I/41V and/or NP-210E/210D in 293T cells in the backbone of A/Anhui/1/2013 (H7N9). Luciferase-based
minigenome reporter assays were used to measure polymerase activity in 293T cells at 33°C (A) or 37°C (B). Cells were co-transfected with Gluc reporter
plasmid and expression plasmids PB2, PB1, and PA of A/Anhui/1/2013 (H7N9), plus different NPs to generate different viral RNPs. After culturing at 33°C
or 37°C for 24 h, Gaussia luciferase production was measured and normalized to AH1 activity. Results are presented as mean ± SEM and are representative
of three independent experiments.
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Figure S1). To investigate whether the NP-41V and/or
NP-210D mutations affect the enzymatic activity of
RNPs, mutations NP-41V and/or NP-210D were intro-
duced into the AH1-NP plasmid using a Site-Directed
Mutagenesis Kit (Saibaisheng, Beijing, China). Con-
versely, mutations NP-41I and/or NP-210E were intro-
duced into the G1-NP plasmid to generate mutant
segments. The presence of the introduced mutation and
the absence of additional unwanted mutations were veri-
fied by sequencing the entire plasmids. We then ana-
lyzed the activities of the recombinant RNP composed of
AH1-PB2, AH1-PB1, AH1-PA, and various NPs (AH1-
NP-WT, AH1-NP-I41V, AH1-NP-E210D, AH1-NP-
I41V-E210D, G1-NP-WT, G1-NP-V41I, G1-NP-D210E,
and G1-NP-V41I-D210E) in 293T cells at different tem-
peratures using a mini-genome replication assay. SimilarA
Figure 3 Replication kinetics of recombinant viruses rgG1-WT, rgG1-NP-V4
or 37°C (B). Confluent monolayers of the various cell lines were inoculated
viruses. Cultured supernatants were harvested at 12, 24, 48, 72, and 96 hpi.
are presented as mean ± SEM and are representative of three independen
rgG1-NP-D210E with rgG1-WT.to the results exhibited in Figure 2, G1-NP-WT increased
AH1-RNP activity at both 33°C and 37°C. Little effect
was observed with G1-NP-V41I and/or G1-NP-D210E at
33°C, but reduced activity of V41I and D210E was shown
at 37°C. Likewise, G1-NP with V41I and D210E decreased
the G1-RNP-WT activities (Additional file 2: Figure S2).
Moreover, AH1-NP with mutations I41V and/or E210D
exhibited 5–20 fold increased RNP activity of AH1-WT at
33°C (Figure 2). These results indicate that residues 41V
and 210D in NP proteins can enhance RNP activities of
AH1 (H7N9), especially at 33°C.
To investigate the effect of NP-41V and/or 210D on
virus replication, recombinant viruses were generated
with reverse-genetics as described previously [21]. For
biosafety concerns, the four rescued viruses were per-
formed using G1 (H9N2) backbones: rgG1-WT, rgG1-
NP-V41I, rgG1-D210E, and rgG1- NP-V41I-D210E.B
1I, rgG1-NP-D210E, and rgG1-NP-V41I-D210E in MDCK cells at 33°C (A)
with rgG1-WT, rgG1-NP-V41I, rgG1-NP-D210E, or rgG1-NP-V41I-D210E
Virus titers were determined by TCID50 assay using MDCK cells. Results
t experiments. *, p < 0.05 and **, p < 0.001, compared the value of
Table 1 Database search for NP-41I/V and/or NP-210D/E mutations in virus isolates from nature
Mutations Human Swine Avian Canine Equine Other residues
NP-41V 6 14 197 42 98 I(13,763), A(2), G(3), K(1), M(1), Q(8), T(6), Y(1)
(n = 357)
NP-210D 9 4 143 0 0 E(13960), G(2), N(9), P(3), Q(2), R(3), X(7)
(n = 156)
NP-41V + 210D 6 0 19 0 0 –
(n = 25)
The data shown are the number of sequences with identical amino acid composition (NP-41 and NP-210) of 14,142 influenza isolates in the NCBI database. The
total number of each residue is shown in parentheses.
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multiplicity of infection (MOI) of 0.001, and incubated
in the appropriate medium containing 2 mg/L N-p-tosyl-
L-phenylalaninechloromethyl ketone-treated (TPCK) tryp-
sin (Sigma, Saint Louis, MO, USA) at 33 or 37°C. At 12,
24, 48, 72, and 96 hours post inoculation (hpi), superna-
tants were harvested and virus titers were determined
using MDCK cells, as described previously [22]. As shown
in Figure 3B, at 37°C, the D210E substitution in the NP
protein significantly decreased the replication ability
of rgG1-WT at early stages post infection (12 and 24 hpi
(p < 0.05; n = 3), although all four viruses demonstrated
comparable growth capability at later stages. Mutation
NP-V41I alone or in combination with D210E, which
showed decreased polymerase activity, exhibited little im-
pact on the growth of rescued virus at 37°C. The apparent
discrepancy between the minigenome reporter assay and
the in vitro virus replication assay in our study may be re-
lated to the different parameters; whereas mRNA synthe-
sis and reporter protein expression is the primary readout
in minigenome assays, for efficient virus replication, a
proper balance between the syntheses of cRNA, vRNA,
and mRNA is required. However, at 33°C, G1 viruses with
the D210E mutation displayed a replication defect
(Figure 3A). The rgG1-WT virus demonstrated better
replication ability to the other three viruses, except
G1-NP-V41I of 72 hpi. These data indicate a growth
advantage of recombinant viruses of rgG1-WT con-
taining NP-41V and NP-210D in MDCK cells at 33°C,
which corresponds to their high polymerase activity in
293T cells.
Sequence alignment of available NP sequences of avian
and mammalian influenza A viruses in NCBI showed
that in 14,142 NP sequences, 357 (2.5%) possess NP-41V
and 156 (1.1%) possess NP-210D (Table 1). Most of the
viruses with NP-41V or NP-210D residues were avian
influenza viruses (197/357 and 143/156, respectively).
However, few NP-41V or NP-210D residues were found
in mammalian influenza viruses, including those of hu-
man and swine-origin viruses. In addition, no such sub-
stitutions have yet been found in the novel H7N9 viruses(data not shown). Despite this, our study revealed that
compared with NP-210D, NP-210E could reduce the
RNP activity of AH1 (H7N9) and G1 (H9N2) viruses,
and could also inhibit the replication of G1 viruses, es-
pecially at 33°C. However, compared with NP-41V,
although viruses with NP-41I were associated with de-
creased RNP activity, no significant variation in virus
growth ability was observed. Therefore, mutations NP-
41V and/or NP-210D may increase the growth capability
of the AH1 (H7N9) virus, particularly in low tem-
perature. Reassortants between G1-like and Y280-like
viruses are not rare [17-19]. Given the continuous muta-
tion and dynamic reassortment [16,23] of H7N9 viruses
in both human and avian hosts, the possibility for these
viruses to obtain these two residues or the entire NP
gene of G1-like viruses cannot be excluded. Therefore,
despite the absence of amino acids 41V and 201D in the
NP of current H7N9 viruses, reassortants with the entire
G1-like NP gene and substitutions of these two residues
in the NP protein are worthy of attention.
Additional files
Additional file 1: Figure S1. Sequence alignment of the NP genes of six
viruses: A/Anhui/1/2013 (H7N9, AH1), A/California/04/2009 (2009pdmH1N1,
CA04), A/Puerto Rico/8/1934 (H1N1, PR8), A/Guangzhou/333/1999
(H9N2, GZ), A/bar-headed goose/Qinghai/1/2005 (H5N1, QH), and A/Quail/
Hong Kong/G1/1997 (H9N2, G1).
Additional file 2: Figure S2. Viral RNA polymerase activities of NP-41I/
NP-41V and/or NP-210E/210D in the background of A/Quail/Hongkong/
G1/1997 (H9N2). 293 T cells were co-transfected with Gluc reporter plasmid
and expression plasmids PB2, PB1, and PA of A/Quail/Hongkong/G1/1997
(H9N2), plus G1 NP with different mutations. After culturing at 37°C for 24 h,
Gaussia luciferase production was measured and normalized to G1 activity.
Results are presented as mean ± SEM and are representative of three
independent experiments.
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infection; MDCK: Madin-Darby canine kidney.
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